Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

被引:141
|
作者
Bouscary, D
DeVos, J
Guesnu, M
Jondeau, K
Viguier, F
Melle, J
Picard, F
Dreyfus, F
FontenayRoupie, M
机构
[1] HOP COCHIN,ICGM,INSERM,U363,F-75679 PARIS 14,FRANCE
[2] HOP HOTEL DIEU,LAB CYTOGENET,F-75181 PARIS,FRANCE
关键词
myelodysplasia; apoptosis; Fas;
D O I
10.1038/sj.leu.2400654
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptosis of hematopoietic progenitor cells is increased in myelodysplastic syndromes (MDS). We have studied Fas (CD95/Apo-1) antigen expression in 27 MDS patients (RARS 4, RA 3, RAEB 13; RAEB-t 3, CMML 4) and three AML secondary to MDS. We found that the Fas antigen was not expressed on normal bone marrow (BM) CD34(+), CD14(+), or glycophorin(+) cells, and only slightly on CD33(+) cells. Patients with MDS had upregulation of Fas expression on total bone marrow nuclear cells (BMMC) (t-test, P = 0.04), CD34(+) (P = 0.013), CD33(+) (P = 0.04), and glycophorin(+) (P = 0.032) BM cells compared to controls. Pas expression did not correlate to the FAB subtype, the Bournemouth score, or to peripheral cytopenias. However, Fas expression intensity on CD34(+) cells negatively correlated to the BM blasts number (Spearman, P = 0.01) suggesting that leukemic blasts cells lose Fas antigen expression with progression of myelodysplasia. Using both proliferation assays in liquid cultures and clonogenic progenitor assays in the presence of an agonist anti-Fas MoAb (CH11), we showed that the Fas protein was functional in some patients. Dose-dependent inhibition of DNA synthesis was observed in three out of seven patients studied. CFU-GM and BFU-E colonies suppression in some patients suggested that Fas can induce apoptosis in myeloid and erythroid BM progenitors of MDS patients, The TUNEL technique on BM smears gave a mean of 12.6% +/- 2.5 of bone marrow apoptotic cells in five controls. Patients with MDS had increased bone marrow apoptosis (mean 39% +/- 5.7, t-test, P = 0.012). Four out of 15 (26%) patients studied with a sensitive radiolabeled DNA ladder technique had typical DNA ladders indicative of advanced stages of apoptosis. Massive BM suicide was observed in patients with RA (2/2) and RAEB (8/11), whereas apoptosis rates were normal or low in patients with RAEB-t (3/3) or secondary AMLs (3/3). Moreover, high rates of apoptosis correlated to low Bournemouth score (Spearman, P = 0.01). No statistical correlation could be found between Fas expression and apoptosis rates. Our results confirm the importance of programmed cell death in MDS, The Fas antigen is clearly upregulated on BM cells, but its role in the pathophysiology of apoptosis in myelodysplasia is still unclear, indicating that many factors positively or negatively interfere with the Fas-mediated pathway of apoptosis in vivo and in vitro.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 50 条
  • [41] Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system
    Jaber, BL
    Perianayagam, MC
    Balakrishnan, VS
    King, AJ
    Pereira, BJG
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (06) : 1006 - 1012
  • [42] Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils
    Luttmann, W
    Opfer, A
    Dauer, E
    Foerster, M
    Matthys, H
    Eibel, H
    Schulze-Osthoff, K
    Kroegel, C
    Virchow, JC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (07) : 2057 - 2065
  • [43] Fas (CD95,APO-1) antigen expression and function in murine mast cells
    Hartmann, K
    WagelieSteffen, AL
    vonStebut, E
    Metcalfe, DD
    JOURNAL OF IMMUNOLOGY, 1997, 159 (08): : 4006 - 4014
  • [44] Apoptosis and Survival in High-grade Astrocytomas as Related to Tumor Fas (APO-1/CD95) Expression
    Bruce Frankel
    Sharon L. Longo
    Christopher Leach
    Gregory W. Canute
    Timothy C. Ryken
    Journal of Neuro-Oncology, 2002, 59 : 27 - 34
  • [45] Influence of interleukin-6 on apoptosis through CD95 (Fas/APO-1) receptor expression in melanoma
    Soubrane, C
    Mouawad, R
    Antoine, EC
    Merle, S
    Coeffic, D
    Delgado, MG
    Khayat, D
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 569 - 573
  • [46] DIFFERENTIAL EXPRESSION OF APO-1 (FAS/CD95) ON HUMAN HEMATOPOIETIC-CELLS
    STAHNKE, K
    KLEIHAUER, E
    DEBATIN, KM
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 888 - 888
  • [47] Apoptosis and survival in high-grade astrocytomas as related to tumor fas (APO-1/CD95) expression
    Frankel, B
    Longo, SL
    Leach, C
    Canute, GW
    Ryken, TC
    JOURNAL OF NEURO-ONCOLOGY, 2002, 59 (01) : 27 - 34
  • [48] Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells
    Villunger, A
    Egle, A
    Kos, M
    Hartmann, BL
    Geley, S
    Kofler, R
    Greil, R
    CANCER RESEARCH, 1997, 57 (16) : 3331 - 3334
  • [49] EXPRESSION OF FAS/APO-1 (CD95) AND APOPTOSIS IN TUMOR-CELLS FROM PATIENTS WITH PLASMA-CELL DISORDERS
    HATA, H
    MATSUZAKI, H
    TAKEYA, M
    YOSHIDA, M
    SONOKI, T
    NAGASAKI, A
    KURIBAYASHI, N
    KAWANO, F
    TAKATSUKI, K
    BLOOD, 1995, 86 (05) : 1939 - 1945
  • [50] Fas/APO-1 (CD95) expression of peripheral T lymphocytes (Ly) in colorectal cancer patients
    Donina, S
    Engele, L
    Jaunalksne, I
    Januskevics, V
    Zakenfelds, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S12 - S12